Akiko Saito-Moriya

13PUBLICATIONS
104CO-AUTHORS
Medical infection agents (incl. prions)Infant and child healthRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 29, 2026
Multi-omics analysis of pediatric minimally differentiated acute myeloid leukemia reveals RUNX1-driven stemness and chemoresistance.

|Feb 25, 2026
Combined Tyrosine Kinase Inhibitors and Chemotherapy Based on Minimal Residual Disease in Children With Ph+ Acute Lymphoblastic Leukemia: A Phase 2 Single-Arm Trial, JCCG ALL-Ph13.

Atsushi Sato, Yuichi Kodama, Hirohide Kawasaki

|Jul 16, 2025
Post-Diagnosis Hemorrhagic Events Are Strongly Associated With Poor Survival in Patients With Essential Thrombocythemia.

Yoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh

|Nov 12, 2024
JCCG ALL-B12: Evaluation of Intensified Therapies With Vincristine/Dexamethasone Pulses and Asparaginase and Augmented High-Dose Methotrexate for Pediatric B-ALL.

Motohiro Kato, Yasuhiro Okamoto, Toshihiko Imamura

|Jun 26, 2024
Phase II Trial of Romidepsin as Consolidation Therapy after Gemcitabine, Dexamethasone, and Cisplatin in Elderly Transplant-Ineligible Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma.

Satoshi Yamasaki, Hiroatsu Iida, Akio Saito

|May 26, 2024
Prognostic factors of idiopathic hypereosinophilic syndrome: A nationwide survey in Japan.

Akira Honda, Yasutaka Masuda, Yu Oyama

Pageof 3

Frequent Collaborators

5 joint publications

Katsuyoshi Koh

5 joint publications

Takao Deguchi

4 joint publications

Nobutaka Kiyokawa

4 joint publications

Daisuke Tomizawa